Results 71 to 80 of about 13,464,365 (277)
Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review
Molecular Oncology, EarlyView.High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo +7 morewiley +1 more sourceExtracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation
Molecular Oncology, EarlyView.Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...Yu Liu, Yubei He, Nikolaus Berndt, Michael Mülleder, Kathrin Textoris‐Taube, Jing Guo, Matthias Stechele, Justus Ramtke, Shraga Nahum Goldberg, Lynn Jeanette Savic +9 morewiley +1 more sourceFunctional and Immunological Relevance of Anaplasma marginale Major Surface Protein 1a Sequence and Structural Analysis. [PDF]
, 2013 Bovine anaplasmosis is caused by cattle infection with the tick-borne bacterium, Anaplasma marginale. The major surface protein 1a (MSP1a) has been used as a genetic marker for identifying A.Barbosa Ribeiro, Mucio Flavio, M. F., Ferrolho, Joana, Zweygarth, Erich, José de la Fuente (35632), Ribeiro, Mucio F. B., Valdés, J.J., Cabezas Cruz, Alejandro, Erich Zweygarth, Katherine M Kocan, Miray Tonk (420443), Rachel Kenneil, Cabezas-Cruz, A., Rachel Kenneil (420441), Anna E. Pohl (420444), Estrada-Peña, A., Miray Tonk, Agustín Estrada-Peña (52766), Ribeiro, M.F.B., Lygia M F Passos, Katarzyna Lis, de la Fuente, J., James J Valdés, Kocan, Katherine M., Zweygarth, E., de la Fuente, José, Mucio F. B. Ribeiro (420448), Alejandro Cabezas-Cruz, Libor Grubhoffer, Lygia M. F. Passos (420439), Estrada-Peña, Agustín, Agustín Estrada-Peña, Lis, K., Katherine M. Kocan (326058), Valdes, James J, Joana Ferrolho (420442), Kenneil, Rachel, Kocan, K.M., Passos, Lygia Maria Friche, James J. Valdés (409724), Passos, Lygia M. F., Erich Zweygarth (420446), Valdés, James J., Shkap, Varda, Pohl, Anna E., Varda Shkap, Pohl, A.E., Varda Shkap (420447), Libor Grubhoffer (420445), Grubhoffer, L., Lis, Katarzyna, Tonk, Miray, Katarzyna Lis (420440), Alejandro Cabezas-Cruz (420438), Cabezas-Cruz, Alejandro, Passos, Lygia, Tonk, M., Mucio F B Ribeiro, Kenneil, R., Anna E Pohl, Joana Ferrolho, Shkap, V., José de la Fuente, Ferrolho, J., Barbosa Ribeiro, Mucio Flavio, Grubhoffer, Libor, Passos, L.M.F., Shkap Varda, Lis Katarzyna, Kenneil Rachel, Tonk Miray, Barbosa Ribeiro, Mucio Flavio,, Zweygarth Erich, Ribeiro Mucio F. B., Pohl Anna E., Kocan Katherine M., Passos Lygia M. F., Fuente, José de la, Ferrolho Joana, Cabezas-Cruz Alejandro, Valdés James J., Grubhoffer Libor, Estrada-Peña Agustín, de la Fuente José +82 morecore +1 more sourceCharacterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers
Molecular Oncology, EarlyView.LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...Marion David, Arthur Karaulic, Audrey Bennetot, Clémence Fournier, Quentin Odet, Arthur Gouraud, Isabelle Bourget, Cédric Gaggioli, Sandy Giuliano, Frédéric Luciano, Olivier Léger, Zaki Sellam, Gilles Pagès +12 morewiley +1 more sourceControl of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes
, 2006 Despite limited data supporting the superiority of dominant over subdominant responses, immunodominant epitopes represent the preferred vaccine candidates.Altfeld, M., Mullins, J.I., Frahm, N., Walker, B.D., Allen, T.M., Kiepiela, P., Adams, S., Lahaie, M.P., Marincola, F.M., Moore, C., Linde, C.H., Sango, K., Mallal, S., Carrington, M., Heckerman, D., Roach, T., Wurcel, A.G., Addo, M.M., Feeney, M.E., Pae, E., Goulder, P.J.R., Brander, C., Korber, B.T., St John, M.A., Hewitt, H.S., Lichterfeld, M., Marylyn M Addo, Marcus Altfeld, David Heckerman, Bette T Korber, Francesco M Marincola, Timothy Roach, Nicole Frahm, Hannah S Hewitt, M Anne St John, James I Mullins, Margaret E Feeney, Simon Mallal, Todd M Allen, Sharon Adams, Kaori Sango, Corey Moore, Alysse G Wurcel, Bruce D Walker, Philip J R Goulder, Eunice Pae, Christian Brander, Mathias Lichterfeld, Caitlyn H Linde, Photini Kiepiela, Matthew P Lahaie, Mary Carrington +51 morecore +1 more sourceIn Silico Identification and in Vitro Analysis of B and T-Cell Epitopes of the Black Turtle Bean (Phaseolus Vulgaris L.) Lectin
Cellular Physiology and Biochemistry, 2018 Background/Aims: The incidence of lectin allergic disease is increasing in recent decades, and definitive treatment is still lacking. Identification of B and T-cell epitopes of allergen will be useful in understanding the allergen antibody responses as ...Shudong He, Jinlong Zhao, Walid Elfalleh, Mohamed Jemaà, Hanju Sun, Xianbao Sun, Mingming Tang, Qian He, Zeyu Wu, Florian Lang +9 moredoaj +1 more sourceReprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy
Molecular Oncology, EarlyView.LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.Gabriel Serra‐Mir, Elena Haro‐Martínez, Sandra Blasco‐Benito, Chiara Cannatà, José Ángel Palomeque, Anna López‐Plana, Maria Sanz‐Flores, Marc Sabartés, Cristina Fornaguera, Toni Celià‐Terrassa +9 morewiley +1 more sourceThe multifaceted roles of lysosomes in cancer
Molecular Oncology, EarlyView.Lysosomes support cancer cell adaptation by integrating macromolecule degradation and nutrient recycling with nutrient sensing, inter‐organelle communication and immune regulation. These interconnected functions can promote tumour growth, stress tolerance and therapy resistance, while also creating context‐dependent vulnerabilities that may be ...Jia Li, Kevin M. Ryanwiley +1 more sourceA simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase [PDF]
, 2007 Background. Abacavir hypersensitivity is strongly associated with the human leukocyte antigen (HLA)–B*5701 allele; however, the cost of routine high-resolution HLA typing before initiation of therapy remains prohibitive.Chui, C.K.S., Brumme, Z.L., Brumme, C.J., Yip, B., Montaner, J.S.G., Phillips, E.J., Harrigan, P.R. +6 morecore